takeda pharmaceutical company

Takeda Pharmaceutical Names U.S. Head Julie Kim

Takeda Pharmaceutical Names U.S. Head Julie Kim as Next CEO

The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who plans to retire in June next year.

Bloomberg L.P. · 1d

Takeda Picks First Woman as CEO of Centuries-Old Drugmaker

Takeda Pharmaceutical Co.’s board has selected Julie Kim, the head of the company’s US unit, to replace Christophe Weber as the drugmaker’s new chief executive officer.

YAHOO!Finance · 23h

Christophe Weber, veteran Takeda CEO, to retire next year

Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top drugmaker.

15hon MSN

Drugmaker Takeda's CEO Weber to step down, raises profit forecast

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's ...

Takeda Pharmaceutical Co.: Hold Rating Amid Mixed Q3 Results, Upward Guidance Revision, and Strategic Moves

Miki Sogi, an analyst from Bernstein, maintained the Hold rating on Takeda Pharmaceutical Co (TKPHF – Research Report). The associated price ...

13h

Takeda Pharmaceutical Company Limited (TAK) Q3 2025 Earnings Call Transcript

Takeda Pharmaceutical Company Limited ( NYSE: TAK) Q3 2025 Results Conference Call January 30, 2025 5:30 AM ET Christopher O’Reilly - Head, Investor Relations Christophe Weber - President and Chief ...

13h

Takeda Prevails Over Sales Rep's Race, Disability Bias Claims

Takeda Pharmaceuticals America Inc. convinced a federal court to toss an employee’s claims that the company discriminated against her for being a White woman with depression and PTSD.